Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
SEATTLE, Jan. 28 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER) today announced that the National Institute on Drug Abuse (NIDA) is providing support for the Company's Addiction...
SEATTLE, Nov. 19 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER) today announced unaudited financial results for the third quarter ended September 30, 2009. For the three months...
SEATTLE, WA, Nov. 13 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on...
SEATTLE, Wash., Oct. 7 /PRNewswire-FirstCall/ -- Omeros Corporation today announced the pricing of its initial public offering of 6.82 million shares of its common stock at a price of $10.00 per...
SEATTLE, Sept. 18 /PRNewswire-FirstCall/ -- Omeros Corporation today announced the launch of its initial public offering of 6.82 million shares of its common stock. Omeros is a clinical-stage...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.19 | 4.63414634146 | 4.1 | 4.48 | 3.93 | 4871 | 4.12352139 | DE |
| 4 | -0.14 | -3.16027088036 | 4.43 | 4.6 | 3.75 | 7532 | 4.12976713 | DE |
| 12 | 0.33 | 8.33333333333 | 3.96 | 4.6 | 3.75 | 8303 | 4.23306491 | DE |
| 26 | 0.66 | 18.1818181818 | 3.63 | 4.6 | 3.4 | 9153 | 4.00475174 | DE |
| 52 | 1.47 | 52.1276595745 | 2.82 | 4.6 | 2.6 | 11880 | 3.58027194 | DE |
| 156 | 0.37 | 9.4387755102 | 3.92 | 4.6 | 2.15 | 10790 | 3.26481304 | DE |
| 260 | 0.59 | 15.9459459459 | 3.7 | 4.6 | 2.15 | 15312 | 3.49885701 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
